This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): RE-001
Description: RE-001 is a recombinant utrophin protein linked to a cell-penetrating moiety allowing for delivery into the cell. It is designed to substitute for dystrophin.
Pink Sheet Keeping Track: A Quintet Of Novel Approvals
Additional information available to subscribers only: